Marshall Wace »

Glycomimetics shares owned by Marshall Wace

Quarter-by-quarter ownership of Glycomimetics (GLYC) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Glycomimetics

Tip: Access up to 7 years of quarterly data

All positions including Glycomimetics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Glycomimetics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2023-12-31 $30k 13k 2.36
2023-06-30 $248k 142k 1.74
2023-03-31 $273k 216k 1.26
2022-12-31 $633k 209k 3.03
2018-12-31 $1.5M 158k 9.47

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Spdr S&p 500 Etf Equity Option Call Option (SPY)
Alphabet Inc-a Equity Option Put Option (GOOGL)
Meta Platforms-a Common Stock (META)
Alphabet Inc-c Common Stock (GOOG)
Walmart Common Stock (WMT)
Abbvie Equity Option Put Option (ABBV)
Las Vegas Sands Common Stock (LVS)
Dr Horton Common Stock (DHI)
Ishares-leh 20 Equity Option Call Option (TLT)
Eli Lilly & Co Right Call Option
General Electric Common Stock (GE)

View all positions for Marshall Wace

Top funds holding Glycomimetics

BVF
Artal Group
NEA Management Company
Octagon Capital Advisors
Vanguard Group
Goldman Sachs Group
GSA Capital Partners
Two Sigma Advisers
Connor, Clark & Lunn Investment Management
Advisor OS
Franklin Resources
Simplex Trading
Two Sigma Investments
Sargent Investment Group
Jane Street

View all funds holding Glycomimetics